Nanomedicine News

RSS

New Project Explores Cytosolic Access and Instability of DNA Nanoparticles

Divita Mathur, Research Assistant Professor, is studying cytosolic access and instability of DNA nanoparticles.

8 Jun 2021

Silver Nanoparticles Inhibit COVID-19 Infection

An international team of scientists from institutions in Mexico, Spain, and Russia has released promising findings from its study investigating the impact of silver nanoparticles on the transmission of COVID-19.

4 Jun 2021

New Nanoparticle Contrast Agents Could Help Better Identify Tumors

A research group from KTH has designed nano-sized particles, in an innovative way, to enhance the detection of tumors present inside the body and in biopsy tissue. The progress could allow early-stage tumors to be identified with lower doses of radiation.

3 Jun 2021

New Class of Hydrogels can Leverage Light for Drug Delivery and Regenerative Medicine

Hydrogels are commonly used inside the body to help in tissue regeneration and drug delivery. However, once inside, they can be challenging to control for optimal use.

3 Jun 2021

Graphene-Based Nanozymes can be Used to Identify L-Cysteine in Serum

Graphene-based materials can be obtained using various reducing agents, many of which are dangerous and toxic chemicals, and the obtained graphene-based materials are prone to aggregation, limiting their practical applications.

2 Jun 2021

Polymeric Nanoparticles Deliver Dopamine to Parkinson’s-Affected Rat Brain

Parkinson’s disease (PD) is a general neurodegenerative disorder that occurs due to the death of dopaminergic neurons in a part of the brain (called substantia nigra pars compacta), which results in a lack of dopamine (DA), one of the principal neurotransmitters active in the central nervous system.

2 Jun 2021

Dolomite Microfluidics and Phosphorex Partner to Accelerate Lipid Nanoparticle Development in the Fields of Drug Delivery and Nanomedicine

Dolomite Microfluidics, a leading developer of particle systems for drug delivery, and Phosphorex, Inc., a leading contract development and manufacturing organization specializing in particle-based formulation of drug products, are pleased to announce their partnership to establish unique capabilities in drug and vaccine development.

From Phosphorex, Inc. 2 Jun 2021